AdvanSix 3Q26 Earnings Conference Call - ADVANSIX INC

Financial Performance:

• Third Quarter 2026 sales increased 15% year-over-year to $431 million, driven by a 17% rise in favorable pricing (10% raw material pass-through, 7% market-based) offset by a 2% volume decline.
• Adjusted EBITDA was $15 million, a $10 million decrease year-over-year, primarily due to $65 million in raw material cost headwinds (sulfur, benzene, propylene) and unfavorable fixed cost absorption from reduced output.
• Adjusted EPS loss was $0.24, declining $0.032 year-over-year; full-year 2026 effective tax rate expected at ~20%.
• Cash flow from operations improved 44% year-over-year to $48 million ($21 million increase) due to working capital discipline; free cash flow generation was $30 million for the quarter.
• Capital expenditures (CapEx) were $18 million (down $8 million YoY); full-year 2026 CapEx guidance is approximately $90 million ($75M base, $15M growth).
• Working capital conversion cycle benchmarks in the top quartile among peers; YTD working capital provided a $24 million cash source compared to a $56 million use in the prior year.

Guidance and Future Outlook:

• Full-year 2026 free cash flow is projected to reach break-even, aided by $15 million in remaining planned CapEx and working capital management; YTD FCF is -$32 million (excluding $18M 45Q refund).
• Fourth-quarter pricing is expected to face a "price-over-raws" headwind, with nylon and chemical intermediates pricing intended to offset rising raw material costs.
• Plant nutrients segment anticipates tighter domestic ammonium sulfate supply and improved demand in H1 2027 due to European capacity rationalization and sustained nitrogen pricing.
• 2027 capital spending is preliminarily estimated at ~$80 million, with peak spend for "Project Century" expected in 2029-2031; Final Investment Decision (FID) for the potential DEF project is targeted for Q2 2027.
• Ammonia sales are projected to rise 25% for the full year; nylon resin production is running ~5% higher year-over-year.

Business Segments and Product Lines:

• Nylon Solutions: Nylon resin sales grew 33% YoY driven by volume increases at the Chesterfield facility; Caprolactam sales were flat with volumes declining in a soft building/construction environment.
• Plant Nutrients: Sales increased 8% YoY, supported by pricing; domestic granular ammonium sulfate volume expected to be strong for the 2026-2027 fertilizer year despite elevated sulfur costs.
• Chemical Intermediates: Sales rose 24% YoY on price and volume improvement; sequential decline driven by timing of acetone shipments and moderating propylene prices.
• Operational Updates: Synthesized ammonium sulfate project commissioned; SUSTAIN program continues to exceed return expectations; 45Q carbon capture tax credit runway supports future cash generation.

Market and Competitive Landscape:

• Sulfur prices moderated to $615/long-ton in Q4 settlements from $705 in Q3; every $100/long-ton sulfur change impacts annualized costs by ~$35 million.
• European capacity rationalization (e.g., Domo insolvency, BASF/HySUN JV considerations) is expected to tighten North American supply into spring 2027.
• Global phenol operating rates remain low due to soft demand, but balanced acetone supply and reduced U.S. imports support near-cycle-average spreads.
• U.S. benzene prices show widening disconnects from Asian/European costs, creating sequential tension in the fourth quarter.
• Customer demand in chemical intermediates (coatings, industrials, electronics) remains broadly stable with "green shoots" monitored in high-value applications.

Risks and Challenges:

• Raw Material Volatility: Rising benzene and sulfur prices remain significant cost headwinds, particularly for plant nutrients where sulfur costs impact margins.
• Market Softness: Declining domestic and export caprolactam volumes driven by a soft building and construction sector and consumer affordability issues.
• Operational Disruption: Reduced production output at Hopewell and Frankfurt sites led to unfavorable fixed cost absorption; winter storm impacts from Q1 2026 also affected rates.
• Regulatory/Administrative: 45Q tax credit refund ($18M expected) timing is subject to DOE/IRS procedural delays; final approval for the USDA "Fields" grant for Project Century is pending.
• Geopolitical: Conflict in the Middle East continues to influence nitrogen pricing and market dynamics.

Management Commentary and Tone:

• Management expressed confidence in the integrated business model's resilience, emphasizing "strong commercial execution" in offsetting inflationary raw material costs.
• Tone was pragmatic yet forward-looking; acknowledged near-term EBITDA pressure but highlighted improved cash conversion and the path to FCF break-even.
• Focus remains on "controllable levers": commercial execution, operational excellence, disciplined capital deployment, and risk-based prioritization of capex.
• Leadership highlighted the strategic importance of the "Project Century" grant and the integration of the DEF project as key growth drivers.

Analyst Questions and Answers:

• Project Century Timing/CapEx: Q&A confirmed the multi-year nature of the project with peak spend in 2029-2031; 2027 spend will be modest (~$80M total CapEx).
• Ammonia Utilization Flexibility: Confirmed ammonia can be flexibly allocated to caprolactam, synthetic ammonium sulfate, merchant sales, or DEF production based on market demand.
• Plant Nutrients Margins: Expectations are for solid pricing retention even as sulfur normalizes, due to base nitrogen value and tight supply dynamics; competitors are challenged by high input costs.
• Operating Rates: Nylon plants (Chesterfield) are up 5% YoY; Caprolactam rates are running 8-10% below optimal due to demand, though Hopewell ammonia remains at high utilization.
• Grant Milestones: USDA "Fields" grant funding is milestone-based and follows administrative reviews similar to previous grants; no major regulatory hurdles anticipated.

Other Key Points:

• Selected for $47 million in proposed USDA "Fields" grant funding for "Project Century," a $98 million, multi-year investment to expand ammonia capacity by 84,000 tons at the Hopewell, VA facility.
• New five-year, $425 million credit facility closed in August with terms comparable to the previous facility, providing ample liquidity.
• Non-manpower fixed cost reduction program is on track for year one savings; target of $30 million total reduction is being executed.
• The company is one of only eight projects selected under the current USDA program, signaling government support for U.S. manufacturing and agricultural resilience.